Apterna
Pre-clinicalApterna is developing precision RNA therapeutics designed to improve liver function in patients with advanced liver disease, with an initial focus on patients whose liver reserve limits access to potentially curative treatment.
Founded
2019
Focus
Drug Delivery
About
Apterna is developing precision RNA therapeutics designed to improve liver function in patients with advanced liver disease, with an initial focus on patients whose liver reserve limits access to potentially curative treatment.
Company Info
TypePrivate
Founded2019
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile